WHO REGIONAL MEETING TAKES PLACE IN BRAZZAVILLE AS MPOX SPREADS. (PHOTO).

 WHO regional meeting takes place in Brazzaville as mpox spreads

The seventy-fourth session of the WHO Regional Committee for Africa takes place in Brazzaville, Republic of Congo, from August 26 to 30, 2024.

The Regional Committee is the WHO decision-making body in the region, which convenes once a year to discuss and endorse policies, activities, and financial plans aimed at improving the health of the people of Africa.

The meeting in Brazzaville comes on the heels of a rapidly spreading mpox virus, TRT AFRIKA reported.

Ahead of the conference, host Congo-Brazzaville has said it is battling to stop the spread of mpox infections, with twenty-one cases already recorded, according to the country's health minister, Gilbert Mokoki, on Sunday.

Mokoki said that the central African country had "registered 158 suspect cases" since the beginning of the year, "21 of which we have confirmed."

The virus has been reported in five of Congo-Brazzaville's 15 regions, with the forested areas of Sangha and Likouala in the north particularly affected.

Mokoki told intending attendees the epidemic was not alarming in Congo-Brazzaville but appealed to everyone to take preventative measures, like regularly washing hands.

Last week, the health agency of the African Union said some 200,000 vaccines would be deployed across Africa, thanks to agreements with the EU and the Danish drugmaker, Bavarian Nordic, whose vaccine was approved in 2019.

But African health ministers at the conference are expected to argue that Africa needs much more.

Congo-Brazzaville alone needed 3 million vaccine doses to end the outbreaks there, which have spilled into at least four nearby African countries.

South African President Cyril Ramaphosa criticised the global response to the 2022 outbreak, calling it unfair as treatments and vaccines were made available to rich Western nations while Africa was given little support.

In a statement, he urged the international community to guarantee “equitable access” to mpox diagnostics and vaccines this time.